HCG.. Big ATH Breakout (On the way, for 500% to 1000% returns)
Fundamentally::
- Cheapest across the Hospital Industry, with 18x CFO to EBITDA
- Cancer care is in the great tailwind across developed economies, which makes HCG a good play for the long run. As India evolves into a developed country, or India positions itself as a medical treatment outsourcer.
- CEO is capable of envisioning a turnaround in the business
Technically::
- Highest strength across its industry peers
- Fresh breakout of all-time high, may go 5-10x from this level in 5-7 years.
Disclaimer:: Biased.
#Very_high_Skin_in_the_game!
- Cheapest across the Hospital Industry, with 18x CFO to EBITDA
- Cancer care is in the great tailwind across developed economies, which makes HCG a good play for the long run. As India evolves into a developed country, or India positions itself as a medical treatment outsourcer.
- CEO is capable of envisioning a turnaround in the business
Technically::
- Highest strength across its industry peers
- Fresh breakout of all-time high, may go 5-10x from this level in 5-7 years.
Disclaimer:: Biased.
#Very_high_Skin_in_the_game!
منشورات ذات صلة
إخلاء المسؤولية
لا يُقصد بالمعلومات والمنشورات أن تكون، أو تشكل، أي نصيحة مالية أو استثمارية أو تجارية أو أنواع أخرى من النصائح أو التوصيات المقدمة أو المعتمدة من TradingView. اقرأ المزيد في شروط الاستخدام.